đź’¨ Abstract
Adverum Biotechnologies Inc. reported a loss of $40.9 million in Q4 2024, with a loss of $1.96 per share and revenue of $1 million. For the year, the loss widened to $130.9 million, or $6.62 per share. Their shares closed at $3.43, a significant drop from $11.73 a year ago.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Chiefs want help along the line in the NFL draft. The question is, offensive or defensive? -
Colorado man convicted of killing his wife after posing as her ex-boyfriend and stalking her -
Facundo Moyano: “El kirchnerismo te usa o te caga” -
Bears hope to land a few more playmakers in the NFL draft -
Texans in desperate need of offensive line upgrade as NFL draft approaches -
Deion Sanders, Buffs face scrutiny over retiring jersey numbers of Shedeur Sanders, Travis Hunter -
Vikings eye defensive backs in NFL draft, with potential to find successor for Harrison Smith -
Can the IRS revoke Harvard’s tax-exempt status? -
A New Hampshire judge is deciding whether to block Trump’s anti-DEI directive to schools -
Va. zoo searching for group of people who broke in, damaged equipment -
Powered by MessengerX.io